First Header Logo Second Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Lesser, Glenn
One or more keywords matched the following items that are connected to Lesser, Glenn
Item TypeName
Academic Article Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: final report of NABTT 97-11.
Academic Article Treatment of relapsed central nervous system lymphoma with high-dose methotrexate.
Academic Article Phase I and pharmacokinetic study of karenitecin in patients with recurrent malignant gliomas.
Academic Article A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas.
Academic Article Suramin and radiotherapy in newly diagnosed glioblastoma: phase 2 NABTT CNS Consortium study.
Academic Article Current therapeutic approaches in patients with brain metastases.
Academic Article Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant glioma.
Academic Article Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma.
Academic Article A phase I dose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiforme.
Academic Article Initial experience with bendamustine in patients with recurrent primary central nervous system lymphoma: a case report.
Concept Neoplasm Recurrence, Local
Academic Article Phase 2 study of dose-intense temozolomide in recurrent glioblastoma.
Academic Article Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas.
Academic Article Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.
Academic Article Anaplastic ganglioglioma: a report of three cases and review of the literature.
Academic Article Impact of temozolomide on gonadal function in patients with primary malignant brain tumors.
Academic Article Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas.
Search Criteria
  • Neoplasm Recurrence Local